The O2Vent is a 3D-printed titanium jaw advancement device custom fitted to a patient’s mouth. The device contains a separate airway that directs air to the back of the mouth, bypassing obstructions in the nose, back of mouth and tongue.
In a recent clinical study of the O2Vent, the device eliminated snoring in 82 percent of patients and significantly reduced snoring in 100 percent of patients. Positive results were seen in people who had nasal obstructions and mainly breathed through their mouths.
“The recent clinical trial data strongly showed that the O2Vent significantly reduced snoring and sleep apnea in most patients studied, even in those who historically did not benefit from other treatments due to chronic nasal obstruction. The trial also demonstrated that the device improves oxygen levels in most patients,” said Chris Hart, MD, Oventus’ founder and clinical director.
The device received clearance from the FDA in March and will be available for sale in the US later this year.
More articles on supply chain:
New device eliminates fear, pain from blood tests
FDA approves new insomnia device
FDA rejects record number of drug applications: 5 main takeaways
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
